BR9602719A - Virus da doença de Merek (MDV sorotipo 1) CEPA I-1585 de MDV vacina para a proteção de aves contra a doença de merek e processo para o desenvolvimento do MDV - Google Patents
Virus da doença de Merek (MDV sorotipo 1) CEPA I-1585 de MDV vacina para a proteção de aves contra a doença de merek e processo para o desenvolvimento do MDVInfo
- Publication number
- BR9602719A BR9602719A BR9602719A BR9602719A BR9602719A BR 9602719 A BR9602719 A BR 9602719A BR 9602719 A BR9602719 A BR 9602719A BR 9602719 A BR9602719 A BR 9602719A BR 9602719 A BR9602719 A BR 9602719A
- Authority
- BR
- Brazil
- Prior art keywords
- mdv
- merek
- disease
- cepa
- development
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95201540 | 1995-06-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9602719A true BR9602719A (pt) | 1998-04-22 |
Family
ID=8220371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9602719A BR9602719A (pt) | 1995-06-12 | 1996-06-07 | Virus da doença de Merek (MDV sorotipo 1) CEPA I-1585 de MDV vacina para a proteção de aves contra a doença de merek e processo para o desenvolvimento do MDV |
Country Status (13)
Country | Link |
---|---|
US (1) | US5789231A (pt) |
EP (1) | EP0748867A1 (pt) |
JP (1) | JPH0998778A (pt) |
CN (1) | CN1147015A (pt) |
AR (1) | AR003003A1 (pt) |
AU (1) | AU5240896A (pt) |
BR (1) | BR9602719A (pt) |
CA (1) | CA2178553A1 (pt) |
HU (1) | HUP9601608A2 (pt) |
IL (1) | IL118613A0 (pt) |
MX (1) | MX9602256A (pt) |
TR (1) | TR199600502A1 (pt) |
ZA (1) | ZA964878B (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0884382A3 (en) * | 1997-06-10 | 2000-10-25 | Pfizer Products Inc. | Processes for preparation of marek's disease virus using continuous mammalian cell lines |
EP1038952A3 (en) * | 1998-12-09 | 2001-06-27 | Pfizer Products Inc. | Processes for preparation of Marek's Disease Virus using continuous avian cell lines |
US6410222B1 (en) | 1998-12-14 | 2002-06-25 | Juridical Foundation The Chemosero-Therapeutic Research Institute | In ovo vaccination of marek's disease type I virus |
AU2003206861B2 (en) * | 2002-02-06 | 2009-04-23 | Lohmann Animal Health Gmbh & Co. Kg | A continuous cell line for the production of vaccines |
FR2857671B1 (fr) * | 2003-07-18 | 2007-10-05 | Centre Nat Rech Scient | Nouveau procede de culture de keratinocytes et ses applications |
US20070111211A1 (en) * | 2003-12-30 | 2007-05-17 | Virumar Pituach Tarkivim Ltd. | Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof |
CN101365484A (zh) | 2005-08-15 | 2009-02-11 | 瓦克辛公司 | 通过给药非复制型载体化疫苗而进行的对禽类的免疫 |
WO2009137146A2 (en) * | 2008-02-25 | 2009-11-12 | Baxter International Inc. | Method for producing continuous cell lines |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1292803A (en) * | 1968-11-18 | 1972-10-11 | Nat Res Dev | Improvements relating to the production of antigens |
US4071618A (en) * | 1974-09-03 | 1978-01-31 | Research Foundation For Microbial Diseases Of Osaka University | Process for preparing virus disease live vaccines |
EP0015074B1 (en) * | 1979-02-06 | 1983-07-20 | Sigmund Stokland | Harvester-thresher |
NL8401120A (nl) * | 1984-04-09 | 1985-11-01 | Centraal Diergeneeskundig Inst | Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek. |
-
1996
- 1996-05-13 EP EP96201311A patent/EP0748867A1/en not_active Withdrawn
- 1996-05-22 AU AU52408/96A patent/AU5240896A/en not_active Abandoned
- 1996-06-06 AR ARP960102975A patent/AR003003A1/es unknown
- 1996-06-07 ZA ZA964878A patent/ZA964878B/xx unknown
- 1996-06-07 JP JP8145575A patent/JPH0998778A/ja active Pending
- 1996-06-07 MX MX9602256A patent/MX9602256A/es unknown
- 1996-06-07 CA CA002178553A patent/CA2178553A1/en not_active Abandoned
- 1996-06-07 BR BR9602719A patent/BR9602719A/pt unknown
- 1996-06-10 IL IL11861396A patent/IL118613A0/xx unknown
- 1996-06-10 US US08/662,450 patent/US5789231A/en not_active Expired - Fee Related
- 1996-06-10 CN CN96111016A patent/CN1147015A/zh active Pending
- 1996-06-11 HU HU9601608A patent/HUP9601608A2/hu unknown
- 1996-06-12 TR TR96/00502A patent/TR199600502A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JPH0998778A (ja) | 1997-04-15 |
US5789231A (en) | 1998-08-04 |
MX9602256A (es) | 1997-01-31 |
AR003003A1 (es) | 1998-05-27 |
IL118613A0 (en) | 1996-10-16 |
ZA964878B (en) | 1997-01-07 |
HUP9601608A2 (en) | 1997-03-28 |
CA2178553A1 (en) | 1996-12-13 |
HU9601608D0 (en) | 1996-07-29 |
CN1147015A (zh) | 1997-04-09 |
AU5240896A (en) | 1997-01-02 |
EP0748867A1 (en) | 1996-12-18 |
TR199600502A1 (tr) | 1996-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9601032A (pt) | Micropartícula e formulação de vacina de dose única | |
BR9605153A (pt) | Vacina de combinação para uso na proteção de galináceos contra a doença de newcastle kit de vacinação para imunizar galináceos contra a doença de newcastle e processo para a prevenção da doença de newcastle em galináceos | |
BR9608405A (pt) | Composto composi-Æo farmaceutica e processo para tratar um paciente que sofre de um distÚrbio fisiolÄgico | |
PT820270E (pt) | Sistema de particulas dispersiveis para a dessensibilizacao dos dentes | |
PT1003478E (pt) | Preparacoes aquosas de aerossol contendo macromoleculas biologicamente activas e processo para a preparacao dos respectivos aerossois | |
FI963281A0 (fi) | Ureaasipohjainen rokote ja helicobakteeri-infektion hoito | |
PT850948E (pt) | Derivados propiofenona e processo para a preparacao dos mesmos | |
BR9607157A (pt) | Composição de xampu anticaspa e processo para produzir a mesma | |
BR9610706A (pt) | Composição aquosa de branqueamento dos dentes e processo para preparar a mesma | |
BR9603544A (pt) | Agentes para o tratamento dos cabelos | |
FI953915A0 (fi) | Dupuytrenin taudin lievittämiseen | |
BR9505612A (pt) | Agente e processo para a ondulação permanente dos cabelos | |
KR970704445A (ko) | 페노티아진 및/또는 티옥산틴을 사용한 알츠하이머 병의 치료 및/또는 예방 방법(methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes | |
BR9403113A (pt) | Agente para tratamento dos cabelos, processo para a deformação permanente dos cabelos e processo para tratamento dos cabelos | |
BR9600147A (pt) | Purin-6-onas 2,9-DI-substituidas processo para sua preparação medicamentos e uso | |
BR9602719A (pt) | Virus da doença de Merek (MDV sorotipo 1) CEPA I-1585 de MDV vacina para a proteção de aves contra a doença de merek e processo para o desenvolvimento do MDV | |
BR9612281A (pt) | Processo para preparação de um 1,2-bis(aciloóxilato) e de um 3,4-diacetóxi-1-buteno | |
BR9610131A (pt) | Agente e processo para o combate a fungos nocivos | |
ZA964679B (en) | Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection. | |
BR9501678A (pt) | Preparação e método para tratamento dos cabelos | |
BR9600356A (pt) | Processo para o tratamento de um reservatório contendo crustáceos | |
BR9607264A (pt) | Composto derivado do isotiuréia composição farmacêutica uso de tal composto e processo para a preparação dos mesmos | |
BR9700026A (pt) | Processo para operar um sistema de proteç o contra roubo e sistema de proteç o contra roubo | |
BR9608120A (pt) | Composição farmacêutica e processo para a preparação da mesma | |
PT94423A (pt) | Processo para a preparacao de um "shampoo" para condicionamento do cabelo, contendo um componente alcool de cadeia longa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer |
Free format text: DIMMINACO AG/SA/LTD (CH) |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |